UNH director receives 292-share equity grant

UNITEDHEALTH GROUP INC director Michele J. Hooper received 292 shares of common stock as dividend equivalents on vested deferred stock units.

Rhea-AI Filing Summary

UNITEDHEALTH GROUP INC director Michele J. Hooper received 292 shares of common stock as dividend equivalents on vested deferred stock units. These dividend equivalents are immediately vested and follow the same terms as the underlying deferred stock units, meaning they function as routine, compensation-related accruals rather than an open-market purchase. After this acquisition, Hooper directly holds a total of 41,586 shares of UnitedHealth Group common stock, indicating this is a small, incremental increase to an existing position.

Insider Trade Summary

Grant/Award: 292 shares

Grant/Award 1 txn

Insider HOOPER MICHELE J

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	292	$0.00	$0.00

Holdings After Transaction: Common Stock — 41,586 shares (Direct)

Footnotes (1)

1. F1. Represents dividend equivalents paid on vested deferred stock units. The dividend equivalents are immediately vested and are subject to the same terms as the underlying deferred stock units.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Michele J. Hooper report for UNITEDHEALTH GROUP INC (UNH)?

Director Michele J. Hooper reported acquiring 292 shares of UnitedHealth Group common stock. These were dividend equivalents on vested deferred stock units, granted at no cost as part of her compensation program rather than through an open-market purchase.

Was the UNH Form 4 transaction by Michele J. Hooper an open-market stock purchase?

No, the transaction was not an open-market purchase. Hooper received 292 shares as dividend equivalents on vested deferred stock units, which are immediately vested and subject to the same terms as the underlying deferred stock units, reflecting routine compensation.

How many UNITEDHEALTH GROUP INC (UNH) shares does Michele J. Hooper hold after this Form 4 filing?

After the reported transaction, Michele J. Hooper directly holds 41,586 shares of UnitedHealth Group common stock. The 292 shares received as dividend equivalents represent a small incremental increase relative to her overall direct ownership position disclosed in the filing.

What does “dividend equivalents on vested deferred stock units” mean for UNH director compensation?

Dividend equivalents mirror cash dividends but are credited in shares on deferred stock units. For Hooper, 292 dividend-equivalent shares were added, immediately vested, and governed by the same terms as her underlying vested deferred stock units, reinforcing equity-based director compensation.

Does the Michele J. Hooper Form 4 for UNH indicate any stock sales or dispositions?

The Form 4 shows no stock sales or dispositions. It reports only an acquisition of 292 common shares classified as a grant or award, arising from dividend equivalents on vested deferred stock units, leaving her post-transaction holdings at 41,586 shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/19/2026 - 04:32 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

HOOPER MICHELE J

(Last) (First) (Middle)

C/O UNITEDHEALTH GROUP INCORPORATED

1 HEALTH DRIVE

(Street)

EDEN PRAIRIE MINNESOTA 55344

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
UNITEDHEALTH GROUP INC [ UNH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/17/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/17/2026		A		292(1)	A	$0	41,586	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents dividend equivalents paid on vested deferred stock units. The dividend equivalents are immediately vested and are subject to the same terms as the underlying deferred stock units.

Remarks:

	Faraz A. Choudhry, Attorney-in-Fact for Michele J. Hooper	03/19/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)